Last update 31 Jul 2025

Nextgen Bioscience Co., Ltd.

Holding Company|2018|South Korea|
www.nextgenbio.co.kr

Overview

Tags

Other Diseases
Immune System Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug4
Top 5 TargetCount
HIF-1α(Hypoxia-inducible factor 1 alpha)1
S1PR1 x S1PR41

Related

4
Drugs associated with Nextgen Bioscience Co., Ltd.
NXC-736
Target
S1PR1 x S1PR4
Mechanism
EDG6 modulators [+1]
Active Org.
Nextgen Bioscience Co., Ltd.
Originator Org.
Nextgen Bioscience Co., Ltd.
Active Indication
Alopecia Areata [+1]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
NXC-828
Target
HIF-1α
Mechanism
HIF-1α inhibitors
Active Org.
Nextgen Bioscience Co., Ltd.
Originator Org.
Nextgen Bioscience Co., Ltd.
Active Indication
Wet age-related macular degeneration
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
NXC-920
Target-
Mechanism-
Active Org.
Nextgen Bioscience Co., Ltd.
Originator Org.
Nextgen Bioscience Co., Ltd.
Active Indication
Idiopathic Pulmonary Fibrosis
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Nextgen Bioscience Co., Ltd.
NCT06104839
/ RecruitingPhase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and Safety of NXC736 in Patients with Moderate and Severe Alopecia Areata
NCT05079425
/ CompletedPhase 1
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect After the Oral Administration of NXC736 in Healthy Male Subjects
100 Clinical Results associated with Nextgen Bioscience Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Nextgen Bioscience Co., Ltd.
Login to view more data
100 Deals associated with Nextgen Bioscience Co., Ltd.
Login to view more data
100 Translational Medicine associated with Nextgen Bioscience Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
2
Preclinical
IND Approval
1
1
Phase 2
Other
11
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free